The resultant α-LGR5scFv CAR T cells exhibited potent and specific killing of LGR5-overexpressing cells as well as LGR5+ pre-B ALL, CRC, and HCC tumour cell lines [22]. This evidence concerns the gene LGR5 and acute lymphoblastic leukemia.